This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Dr. Reddy's Laboratories Ltd. acquired a portfolio of eight Abbreviated New Drug Applications in the US from Teva Pharmaceutical Industries Ltd. for $350mm in cash. The products include buprenorphine/naloxone sublingual film, ethinyl estradiol/etonogestrel vaginal ring, ezetimibe/simvastatin tablets, metformin/saxagliptin ER tablets, tobramycin inhalation solution, phentermine/topiramate ER capsules, imiquimod topical cream, and ramelteon tablets.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?